Yoshiyuki Aikawa
Chairman and CEO, Director, 10% Owner · SBC Medical Group Holdings Inc
IndividualSelling only
- 2026
- Apr 30, 2026
- 3
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Yoshiyuki Aikawa's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $117.62M in ARTV purchases and sales in the last 12 months
- SVF Pauling (Cayman) Ltd - $116.40M in RLAY purchases and sales in the last 12 months
- Bain Capital Life Sciences Investors, LLC - $115.00M in HTFL purchases and sales in the last 12 months
- Michael Simanovsky - $110.65M in SNDA purchases and sales in the last 12 months
- Mayukh Sukhatme - $109.13M in ROIV purchases and sales in the last 12 months
- Emily M. Leproust - $101.55M in TWST purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Yoshiyuki Aikawa?
Yoshiyuki Aikawa is a corporate insider, tracked as Chairman and CEO, Director, 10% Owner of SBC Medical Group Holdings Inc (SBC). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Yoshiyuki Aikawa last file a Form 4?
The most recent primary Form 4 on record is dated 30 April 2026, one of 3 filings going back to 2026.
Has Yoshiyuki Aikawa been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($20.15M) across all tracked filings.
